203 related articles for article (PubMed ID: 38246207)
1. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
2. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
3. The Oxindole GW-5074 Inhibits JC Polyomavirus Infection and Spread by Antagonizing the MAPK-ERK Signaling Pathway.
Kaiserman J; O'Hara BA; Garabian K; Lukacher A; Haley SA; Atwood WJ
mBio; 2023 Apr; 14(2):e0358322. PubMed ID: 36786589
[TBL] [Abstract][Full Text] [Related]
4. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
5. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
6. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of JC polyomavirus infectivity by the retrograde transport inhibitor Retro-2.1.
Treasure T; Nelson CDS
Microbiol Immunol; 2020 Dec; 64(12):783-791. PubMed ID: 32965709
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract][Full Text] [Related]
10. GRK2 mediates β-arrestin interactions with 5-HT
Mayberry CL; Wilczek MP; Fong TM; Nichols SL; Maginnis MS
J Virol; 2021 Mar; 95(7):. PubMed ID: 33441347
[TBL] [Abstract][Full Text] [Related]
11. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
12. A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses.
Nelson CD; Carney DW; Derdowski A; Lipovsky A; Gee GV; O'Hara B; Williard P; DiMaio D; Sello JK; Atwood WJ
mBio; 2013 Nov; 4(6):e00729-13. PubMed ID: 24222489
[TBL] [Abstract][Full Text] [Related]
13. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3'-Kinase γ Facilitates Polyomavirus Infection.
Clark P; Gee GV; Albright BS; Assetta B; Han Y; Atwood WJ; DiMaio D
Viruses; 2020 Oct; 12(10):. PubMed ID: 33092168
[TBL] [Abstract][Full Text] [Related]
15. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.
Kaiserman J; O'Hara BA; Haley SA; Atwood WJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239927
[TBL] [Abstract][Full Text] [Related]
16. Polyomavirus Wakes Up and Chooses Neurovirulence.
Butic AB; Spencer SA; Shaheen SK; Lukacher AE
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896889
[TBL] [Abstract][Full Text] [Related]
17. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
18. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
19. JC polyomavirus DNA detection in clinical practice.
Kartau M; Auvinen E; Verkkoniemi-Ahola A; Mannonen L; Helanterä I; Anttila VJ
J Clin Virol; 2022 Jan; 146():105051. PubMed ID: 34883406
[TBL] [Abstract][Full Text] [Related]
20. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
